Mirum Pharmaceuticals (MIRM) Stock Price, Quote, News & History

Q: What sector and industry does Mirum Pharmaceuticals (MIRM) operate in?

Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Mirum Pharmaceuticals (MIRM) Stock Price, Quote, News & History

MIRMNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$105.45

1.651.59%

At close: Feb 2, 4:00 PM EST

$105.45

1.651.59%

Pre-Market: 9:03 AM EST

Overview

News Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

-

Close

$105.45

Volume / Avg.

403.00 / 768.27K

Day Range

- - -

52 Wk Range

36.88 - 105.64

Market Cap

$6.31B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

84

Short Interest

13.97%

Days to Cover

9.09

Recent Mirum Pharmaceuticals Inc News

Top 3 Health Care Stocks That May Implode In Q1

Avi Kapoor

Carnival Posts Strong Q4 Earnings, Joins Amicus Therapeutics, Biomarin Pharmaceutical And Other Big Stocks Moving Higher On Friday

Avi Kapoor

This Riot Platforms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

44.69M

Investing Cash Flow (TTM)

-24.32M

Financing Cash Flow (TTM)

36.48M

Free Cash Flow (TTM)

44.32M

Capital Expenditure (TTM)

-374.00K

Net Change in Cash (TTM)

56.86M

Analyst Trends and Forecast

1

Oct 25

2

Nov 25

5

Dec 25

3

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.26B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

11.03

PB Ratio (TTM)

21.62

Earnings Yield % (TTM)

-0.80%

Earnings Yield % (FWD)

-0.05%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

117.43

Book Value / Share

$4.88

Company Debt

Total Debt

$309.37M

LT Debt

$309.37M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$282.02M

Debt to Equity

1.09

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$105.45

Volume / Avg.

403.00 / 768.27K

Day Range

- - -

52 Wk Range

36.88 - 105.64

Market Cap

$6.31B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

84

Short Interest

13.97%

Days to Cover

9.09

About

Sector

Health Care

Industry

Biotechnology

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered,...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Mirum Pharmaceuticals (MIRM) stock?

A

You can purchase shares of Mirum Pharmaceuticals (NASDAQ:MIRM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Mirum Pharmaceuticals (MIRM) competitors?

A

Other companies in Mirum Pharmaceuticals’s space includes: Immunovant Inc (NASDAQ:IMVT), Celcuity Inc (NASDAQ:CELC), Cogent Biosciences Inc (NASDAQ:COGT), Alkermes PLC (NASDAQ:ALKS) and PTC Therapeutics Inc (NASDAQ:PTCT).

Q

What is the forecast, or price target, for Mirum Pharmaceuticals (MIRM) stock?

A

Mirum Pharmaceuticals has a consensus price target of $85.94.

Q

What is the current price for Mirum Pharmaceuticals (MIRM)?

A

The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $105.45 last updated February 3, 2026 at 4:00 PM EST.

Q

Does Mirum Pharmaceuticals (MIRM) pay a dividend?

A

There are no upcoming dividends for Mirum Pharmaceuticals.

Q

When is Mirum Pharmaceuticals (NASDAQ:MIRM) reporting earnings?

A

Mirum Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Mirum Pharmaceuticals (MIRM) going to split?

A

There is no upcoming split for Mirum Pharmaceuticals.

Q

What sector and industry does Mirum Pharmaceuticals (MIRM) operate in?

A

Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Cogent Biosciences Inc

Protagonist Therapeutics Inc

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

-

Close

$105.45

Volume / Avg.

403.00 / 768.27K

Day Range

- - -

52 Wk Range

36.88 - 105.64

Market Cap

$6.31B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

84

Short Interest

13.97%

Days to Cover

9.09

Recent Mirum Pharmaceuticals Inc News

Top 3 Health Care Stocks That May Implode In Q1

Avi Kapoor

Carnival Posts Strong Q4 Earnings, Joins Amicus Therapeutics, Biomarin Pharmaceutical And Other Big Stocks Moving Higher On Friday

Avi Kapoor

This Riot Platforms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

44.69M

Investing Cash Flow (TTM)

-24.32M

Financing Cash Flow (TTM)

36.48M

Free Cash Flow (TTM)

44.32M

Capital Expenditure (TTM)

-374.00K

Net Change in Cash (TTM)

56.86M

Analyst Trends and Forecast

1

Oct 25

2

Nov 25

5

Dec 25

3

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.26B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

11.03

PB Ratio (TTM)

21.62

Earnings Yield % (TTM)

-0.80%

Earnings Yield % (FWD)

-0.05%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

117.43

Book Value / Share

$4.88

Company Debt

Total Debt

$309.37M

LT Debt

$309.37M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$282.02M

Debt to Equity

1.09

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

-

Close

$105.45

Volume / Avg.

403.00 / 768.27K

Day Range

- - -

52 Wk Range

36.88 - 105.64

Market Cap

$6.31B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

84

Short Interest

13.97%

Days to Cover

9.09

About

Sector

Health Care

Industry

Biotechnology

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered,...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry